When Is Protein Refolding the Right Strategy?

Producing sufficient quantities of active, high-quality protein remains one of the most common challenges in drug discovery and protein science. While Escherichia coli remains a widely used expression system due to its speed, scalability, and cost effectiveness, recombinant proteins do not always behave as expected. In many cases, proteins are produced as insoluble aggregates known as inclusion bodies, creating a critical decision point: should you pursue protein refolding or explore an alternative expression strategy?

At Sygnature Discovery, selecting the most appropriate route to functional protein is often as important as the downstream purification and characterization process itself. While protein refolding can be highly effective for certain targets, success is far from guaranteed, making informed decision-making essential.

The Promise of Protein Refolding

The concept of protein refolding stems from the pioneering work of Christian Anfinsen, who demonstrated that a protein’s three-dimensional structure is determined by its amino acid sequence. In principle, this means that proteins produced in an unfolded state can be returned to their native, biologically active conformation under the right conditions.

If protein refolding were universally successful, many recombinant proteins would simply be expressed as inclusion bodies, isolated, solubilized using denaturants, and refolded in vitro. In practice, however, protein folding is often more complex. Many proteins rely on precise disulfide bond formation, post-translational modifications, or cellular folding machinery to achieve their native structure.

As a result, protein refolding remains a specialized but valuable approach within protein production workflows.

When Is Refolding Worth Considering?

Although predicting refolding success is difficult, some proteins are generally better candidates than others.

As a rule of thumb, proteins may have a higher likelihood of successful refolding when they are:

• Relatively small secreted proteins, typically less than 30 kDa
• Dependent on a limited number of disulfide bonds
• Not heavily glycosylated

Under the right circumstances, refolding can provide an efficient route to producing substantial quantities of protein from inclusion bodies, avoiding the need for more complex expression systems.

However, not every aggregation-prone protein is a good refolding candidate. For many targets, alternative expression approaches may ultimately provide a faster and more reliable path to functional protein.

Measuring Success Beyond Solubility

One of the most common misconceptions in protein refolding is equating solubility with successful folding.

A soluble protein is not necessarily a correctly folded protein. Misfolded proteins can remain soluble while exhibiting little or no biological activity. For this reason, establishing a reliable assay to assess protein function or structure is critical before embarking on a refolding campaign.

Depending on the target, success may be measured through:

• Biological activity assays
• Binding studies
• Biophysical characterization
• Structural analysis
• Stability assessments

Without a meaningful method to assess native structure or function, determining whether refolding has truly succeeded becomes difficult.

Designing an Effective Refolding Strategy

Protein refolding is often best approached as a systematic screening exercise rather than a single experiment.

Researchers such as Rainer Rudolph have extensively described strategies for optimizing protein refolding, emphasizing the importance of evaluating multiple parameters simultaneously. Statistical experimental designs can be particularly valuable for identifying productive conditions while minimizing experimental effort.

Common variables explored during refolding screens include:

• pH
• Protein concentration
• Reducing and oxidizing agent concentrations
• Salt concentration
• Temperature
• Additives that suppress aggregation
• Refolding rate
• Buffer composition

Even small changes in these parameters can have a significant impact on refolding efficiency and protein recovery.

Knowing When to Pivot

One of the most important aspects of protein refolding is recognizing when to stop.

Refolding campaigns can consume significant time and resources, particularly when no evidence of properly folded protein emerges during initial screening. When multiple conditions fail to generate active protein, continuing optimization may not be the most productive use of resources.

This is where scientific experience becomes especially valuable.

Rather than investing months in increasingly complex refolding experiments, it may be more effective to evaluate alternative solutions such as:

• Construct redesign
• Fusion tag optimization
• Co-expression strategies
• Insect cell expression
• Mammalian cell expression
• Alternative protein engineering approaches

The most successful protein production programs are not necessarily those that persist with a single strategy, but those that rapidly identify the most promising route forward.

Balancing Opportunity and Risk

Protein refolding occupies an important place within the protein scientist’s toolkit. For the right target, it can provide a straightforward and scalable route to active protein production. For others, alternative expression systems may offer a more reliable path to success.

The challenge lies in understanding which approach is most likely to deliver high-quality protein within the constraints of a project timeline.

At Sygnature Discovery, our Protein Science teams routinely evaluate multiple expression and production strategies to overcome challenging protein targets. By combining expertise in bacterial, insect, and mammalian expression systems with extensive protein characterization capabilities, we help clients identify the most efficient route to functional protein while minimizing development risk.

Conclusion

Protein refolding can be a powerful solution for proteins expressed as inclusion bodies, but it is rarely a one-size-fits-all answer. Success depends on the properties of the target protein, the availability of suitable analytical assays, and a structured approach to process optimization.

Ultimately, the key question is not simply whether a protein can be refolded, but whether refolding represents the most efficient path to obtaining the active protein needed to advance a discovery program. Knowing when to pursue refolding and when to pivot to an alternative strategy can make the difference between a prolonged optimization effort and a successful protein production campaign.